Dr. Robesti on Optimizing Patient Selection for Salvage Lymph Node Dissection in Prostate Cancer

Video

Daniele Robesti, MD, discusses how to optimize patient selection for salvage lymph node dissection in prostate cancer.

Daniele Robesti, MD, second-year resident, Università Vita-Salute San Raffaele, discusses how to optimize patient selection for salvage lymph node dissection in prostate cancer.

Salvage lymph node dissection is a treatment option for patients with prostate cancer who have experienced recurrence, Robesti says. However, patients should be properly selected to undergo this kind of treatment, since there are several options for patients in this setting, and outcomes of salvage lymph node dissection can vary, Robesti adds.

Salvage lymph node dissection is a surgical treatment that is typically done after the radical prostatectomy, and patient selection is crucial, since the approach is associated with several comorbidities, Robesti explains. Ideal patients for salvage lymph node dissection are those who can maintain progression-free survival and avoid the administration of hormonal therapy, and these patients can have an improved quality of life and improved oncological outcomes, Robesti concludes.

Related Videos
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Elias Jabbour, MD
Shruti Tiwari, MD
Jeffrey P. Townsend, PhD
Marina Baretti, MD
George R. Simon, MD, FACP, FCCP
Saad Z. Usmani, MD, MBA, FACP, FASCO
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD